How insecticides and temperature affect the spread of dengue virus by mosquitoes
Impact of insecticide control measures and temperature on Dengue Virus transmission by Aedes aegypti mosquitoes
This study looks at how temperature and the use of insecticides affect the spread of dengue virus by mosquitoes, aiming to find better ways to prevent dengue outbreaks and help keep you and your community safe.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Notre Dame NIH-funded |
| Lab location | 1 site (Notre Dame, United States) |
| Project ID | NIH-10900909 on NIH RePORTER |
What this research studies
This research investigates how temperature and insecticide use influence the transmission of the dengue virus by Aedes aegypti mosquitoes. By developing predictive models that incorporate both temperature and insecticide effects, the study aims to better understand and mitigate the risks associated with dengue outbreaks. The approach involves analyzing the interaction between these factors and their impact on mosquito behavior and virus transmission rates. Patients can benefit from improved strategies to control dengue transmission, potentially leading to reduced incidence of the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in regions where dengue is prevalent, particularly those who may be at risk of infection due to environmental factors.
Not a fit: Patients who live in areas where dengue is not endemic or who are not at risk of exposure to Aedes aegypti mosquitoes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for controlling dengue virus transmission, ultimately reducing the number of cases and deaths associated with the disease.
How similar studies have performed: Previous research has shown success in using predictive models to understand mosquito-borne disease transmission, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Notre Dame, United States
- University of Notre Dame — Notre Dame, United States (Active)
Researchers
- Principal investigator: Heffernan, Patrick — University of Notre Dame
- Study coordinator: Heffernan, Patrick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.